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Pain outcomes in children who received intrathecal vs
intravenous opioids for pain control following major
urologic surgery: a retrospective review
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What is already known
• Intrathecal opioid administration has been associated with short-term postoperative benefits including reduced
pain and opioid use and longer interval to morphine rescue in children.
What this study adds
• Intrathecal opioids were associated with reduced need for intravenous opioids for the first 16 h after urologic
surgery with no discernible difference thereafter. Children who received intrathecal opioids experienced higher
rates of pruritus, constipation, and hypotension than those who received intravenous opioids.
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Summary
Background: Intrathecal (IT) opioid administration has been associated with
postoperative benefits including reduced pain and opioid use in children.
However, the postoperative benefits and risks of IT opioid administration
during major urologic surgery in children remain unclear.
Aim: The aim of this study was to compare postoperative pain and adverse
event outcomes among children who received IT vs intravenous (IV) opioids
during major urologic surgery.
Methods:We reviewed the medical records of children 3–17 years of age who
underwent ureteroneocystostomy or pyeloplasty between 2006 and 2012.
Electronically captured anesthetic and surgical data, postanesthesia care
recovery unit (PACU) and nursing flowsheets, and daily progress notes
through hospital discharge were reviewed. Analgesic techniques (i.e., IT or IV
patient/nurse controlled opioids), all analgesic drugs and doses were
recorded. Outcome measures included pain scores, need for rescue analgesics,
opioid-related adverse events, and their treatments.
Results: Seventy-seven children received IT opioids and 51 received IV
opioids. More children in the IV group required rescue analgesics and had
higher pain scores at PACU discharge. Children in the IV group required res-
cue opioids more frequently than the IT group from 0 to 8 h and 8 to 16 h
after PACU discharge, but rates were similar by 16–24 h 70% of children in
IT group transitioned directly to oral opioids. Seven IT placements were con-
sidered as failed due to early need for rescue opioids. Four (8%) of the IV
group and seven (9%) of the IT group experienced oxygen desaturation. Two
of these, both in IT group required naloxone and one was admitted to ICU
for observation. The IT group experienced a higher incidence of pruritus,
constipation and hypotension.
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Conclusion: We observed better postoperative pain control in children who
received IT vs IV opioids for the first 16 h with no discernible difference
thereafter. The intrathecal group experienced higher incidences of pruritus,
constipation, and hypotension.
Introduction
Intrathecal (IT) morphine has been used as an analgesic
adjuvant during cardiac, orthopedic, abdominal, and
urological surgery in children (1,2). Several randomized
trials have shown that children who received IT mor-
phine intraoperatively had reduced pain and opioid
requirements in the postoperative period following
hypospadias repair (3), cardiac surgery (4), and spinal
fusion (5). In this latter study, children had also received
intravenous (IV) opioids via the patient controlled anal-
gesia (PCA) method. Retrospective studies, in children
who underwent a variety of surgeries, similarly found
those who received IT morphine in addition to general
anesthesia had reduced intraoperative and postoperative
opioid use compared to those who received nalbuphine
PCA (5–7). Studies have also found that in children who
received IT opioids the interval to IV morphine rescue
was longer compared to those who received intraopera-
tive IV opioids alone (3,4,8) or IT placebo (2,6,9). A
retrospective review of 187 children receiving low dose
IT opioids for a range of major open and laparoscopic
surgical procedures found that 16% of patients did not
require any postoperative opioids (7).
Although the short-term postoperative benefits of IT
opioid administration during surgery have been demon-
strated, little is known about related adverse events.
Retrospective data vary showing that pruritus, nausea,
and vomiting are the most common side effects across a
range of IT opioid doses with an incidence of these
effects varying from 6% (3) to 35% (7). Urinary reten-
tion rates for children who received IT opioids have also
varied widely, from 3% to 59% (6,7,10,11). More
serious adverse effects of IT opioids include sedation
and respiratory depression (9,12) and postdural punc-
ture headache (1,7,8). However, randomized controlled
trials comparing IT and IV opioids have found similar
and low rates (<5%) of respiratory complications in
both groups (3,4).
Larger, multi-center registries of anesthesiologist self-
reported pediatric regional cases have, to date, included
only a small proportion of cases where IT block was
used (≤2%), and these have reported few major adverse
events (10–12). In one of these, a single case of inadver-
tent intravascular injection (of unspecified intrathecal
medication) was reported among 506 IT injections (10),
and in another, 3 of 386 cases had ‘extended spinal
blocks/total spinal anesthesia’ (11). From the Pediatric
Regional Anesthesia Network (PRAN) database which
included cases from North America, only one adverse
event (i.e., hypotension in an adolescent girl) was
reported in 83 IT blocks (12). Although these databases
suggest a very low rate of serious complications from IT
injections, they do not differentiate between IT anesthe-
sia and IT analgesia, nor give details of the drugs used.
Significant adverse events are reported but rates of
common side effects are not. From these self-reported
registries, use of IT opioids, bupivacaine, or combined
drugs could not be discerned, and thus, there are sparse
data regarding outcomes related to IT analgesia.
Despite these studies, the benefits and risks of intraop-
erative IT morphine as they pertain to the postoperative
course following major urologic surgery in children
remains unclear. We, therefore, designed this study to
retrospectively review and compare pain and adverse
event outcomes among children who received IT vs IV
opioids for postoperative pain management following
major urologic surgery.
Methods
Approval was obtained from the Institutional Review
Board at the University of Michigan Medical School,
and a waiver of consent was granted to collect de-identi-
fiable patient data for this study. We used our anesthe-
sia electronic database (Centricity; General Electric
Healthcare, Waukesha, WI, USA) to identify all
children 3–17 years of age who underwent ureteroneo-
cystostomy or pyeloplasty. During 2009 and 2010, the
use of regional anesthesia had expanded at our institu-
tion and, specifically, IT administration of morphine
became a routine practice to manage pain for children
having major urologic surgery. Prior to this time, anal-
gesia was managed using IV delivery of opioids either
by PCA pump or nurse-controlled administra-
tion (NCA). For this study, we included children who
underwent surgery between 2006 and 2012, to ensure a
sufficient sample who had received either IT or IV
opioid delivery over a period during which the surgical
practices remained largely unchanged. We excluded chil-
dren who received non-IT regional analgesia (i.e., epidu-
ral or caudal blocks), and children under 3 years of age
(to reduce the potential for unreliable self-reported pain
scores).
© 2015 John Wiley & Sons Ltd
Pediatric Anesthesia 25 (2015) 1280–1286
1281
E.M. Putnam et al. Intrathecal vs intravenous opioids
Trained research assistants carefully reviewed the
medical records of all subjects and recorded the follow-
ing data: patient demographics, ASA physical status,
surgical procedure, anesthetic technique, and routes and
amounts of all intra- and postoperative opioids and
adjuvant analgesics administered. Duration of induction
(i.e., time from onset to incision), surgery (i.e., incision
to surgical dressing time), emergence (i.e., surgical dress-
ing completed to extubation), and hospital stay were
calculated from electronically captured data.
The following outcome data were also recorded from
the postanesthesia care recovery unit (PACU) and
nursing flowsheets for each 8-h period after PACU dis-
charge for 24 h, and during each 24-h period thereafter
until hospital discharge: highest pain scores (i.e. 0–10
numeric pain ratings), depth of sedation (i.e. University
of Michigan Sedation Scores 0–4, where 0 = awake/
alert to 4 = unrousable), and vital signs including low-
est SpO2 from continuous pulse oximetry capture (rou-
tine in our setting), lowest respiratory rate (RR), heart
rate (HR), and systolic blood pressure (BP).
All analgesic-related and surgical adverse events and
their treatments were identified from review of flow-
sheets, progress notes (surgical and acute pain team),
and medicine administration record through 30 days
after discharge (via clinic documentation). Adverse
events and their possible treatments included: pruritus
(diphenhydramine), nausea/vomiting (antiemetic),
oxygen desaturation and respiratory depression (nalox-
one and supplemental oxygen), constipation (laxa-
tives), hypotension (defined as a 20% decrease from
baseline and/or requirement of an IV fluid bolus),
infection (i.e., fever with/without treatment), and post-
dural puncture headache (with/without blood patch
treatment). All children for whom spinal analgesia was
placed or attempted were included and failed IT anal-
gesia was defined as the need for IV opioid rescue in
<8 h following IT injection. The medical records of
children who were identified as having a failed spinal,
postdural puncture headache, escalation of care or
with any other questionable data underwent a sec-
ondary and independent review by one of the anesthe-
siologist investigators (i.e., EMP or PK) to ensure the
integrity and reliability of data.
Statistical analysis
All analyses were conducted with SPSS (v.21; IBM,
Armonk, NY, USA) and data are presented as n
(%) or mean  standard deviation. Comparisons for
nominal data (e.g., sex) were made between groups
using chi-square with Fisher’s exact tests. Continuous
variables were compared using unpaired t-tests (cor-
rected as appropriate based on Levene’s test for
equality of variance). Opioids were converted to
morphine equivalents per kilogram of the child’s
weight and were standardized to the time spent in
the hospital, for comparisons. Pain scores were trea-
ted as continuous data, and a repeated measures
analysis of variance was used to compare pain scores
between groups. Statistical significance was accepted
if P values were <0.05, and Bonferroni corrections
were applied for the repeated measures.
Results
One hundred and fifty-eight children underwent uretero-
neocystostomy or pyeloplasty during our study period;
however, 30 children were either <3 years of age or had
received an excluded regional technique. Thus, data
from 128 patients were analyzed. Seventy-seven children
had received IT hydromorphone (all after 2009), and 51
(96% from 2006 to 2008), IV opioids as their primary
mode of postoperative analgesia. There were no signifi-
cant differences in ASA status, gender, and age or
operation type between the IT and IV groups (Table 1).
Perioperative data
Table 2 presents a description of the intraoperative
care of children in the groups. There was a small but
significant increase in the induction time for children
in the IT group. Sixty-two (81%) children in the IT
group had co-administration of bupivacaine 0.75%
(mean volume 0.04  0.015 mlkg1) and none had
bupivacaine without IT opioid. Preservative-free mor-
phine (Duramoph) was the IT opioid used in all
patients and the mean dose was 4.4 lg per kg
(0.59 lg). As expected, the intraoperative analgesia
management of children differed significantly between
the two groups (see Table 2). Additionally, in the
PACU, significantly more children in the IV group
required rescue opioid (Table 2).
Table 1 Characteristics of the study groups (data presented as n
[%] or mean  SD where applicable)
Intrathecal
(n = 77) (%)
Intravenous
(n = 51) (%) P value
Age (years) 7.24  3.40 8.0  2.97 0.232
Female 57 (74.0) 30 (59) 0.071
ASA 1 20 (26.0) 17 (33.3) 0.194
2 56 (72.7) 31 (60.8) –
3 1 (1.3) 3 (5.9) –
Pyeloplasty 18 (23.4) 16 (31.4) 0.36
Ureteroneocystostomy 59 (76.6) 35 (68.6) –
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Postoperative analgesia outcomes
After PACU discharge, children in the IV group
received opioids via PCA/NCA pump (n = 41 [80%])
or intermittently as needed (n = 10 [20%]). In contrast,
a majority in the IT group were transitioned directly to
oral opioids (n = 54 [70%]), while fewer received PCA/
NCA (n = 12 [16%]) or intermittent IV (n = 9 [12%])
opioids. Nearly all children in the IV group (n = 49
[96%]) required IV opioids within the first 8 h after
PACU discharge, compared to only 11 (14%) in the IT
group (P < 0.001). In seven (9%) of the IT cases, the
anesthesiologist had documented difficulty with the
technique and these were, thus, recognized as having
failed at the time of placement. Overall, the time to
need for opioid rescue in the IT group was
15.6  7.9 h (Median 19; range 0–33; IQR 13–21 h).
The proportion of children who received opioids was
also greater in the IV group from 8 to 16 h postopera-
tively (47 [92%] vs 25 [33%]; P < 0.001) but was similar
by 16–24 h (46 [90%] vs 70 [91%]; P = 0.892). Total
opioid use over the course of the hospital stay was signifi-
cantly higher for the IV group compared to the IT group
(0.01  0.005 vs 0.005  0.004 mg oral morphine equiv-
alents per kgh1 of stay; P < 0.001). Conversely, aceta-
minophen use was higher for the IT group (1.48  1.04
vs 0.72  0.67 mgkg1h1 of stay; P < 0.001) and
ketorolac administration was not different (0.01  0.02
vs 0.01  0.02 mgkg1h1; P = 0.154). As shown in
the Figure, average pain scores for both groups were,
overall, low and there was a large and significant effect of
time from baseline (PACU), where scores went up for the
IT group, but did not change for the IV group (Interac-
tion Time*Group tested with Wilks’ Lambda 2.76;
P = 0.032; partial eta squared 0.324). There was no main
effect for group (IV/IT) on pain scores in this sample
(F = 0.498; P = 0.484; partialg2 = 0.011).
Adverse events
The overall incidence of opioid-related adverse effects
was higher for the IT group (75% vs 67%); however,
this did not reach statistical significance in this sample
(P = 0.092) (Table 3). The incidence of bothersome but
not dangerous side effects, including nausea, vomiting,
and pruritus, was high in both groups. The rates of pru-
ritus, constipation, and hypotension were significantly
higher in the IT group. The rates of respiratory compro-
mise were similar in both groups and included: Seven
cases of oxygen desaturation in the IT group (9%)—five
requiring supplemental oxygen, and four (8%) in the IV
group, all requiring oxygen. Of these, two children (both
in the IT group) required naloxone administration in the
PACU and one was admitted to the intensive care unit
for observation. Due to the clinical presentation of
these patients, an inadvertent opioid overdose was sus-
pected and documented. There was no difference in the
length of hospital stay between the two groups (IT
group 2.48  1.59 days; IV group 2.74  0.41 days; P
= 0.413).
During the 30-day follow-up period, two children in
the IT group and four in the IV group had complained
of nausea and vomiting shortly after discharge from
hospital. Similar numbers in both groups reported ongo-
ing pain: seven (9%) in the IT group and five (10%) in
the IV group. Two children in the IT group had reported
headache without intervention in the early days after
discharge. The documented details of headache in these
cases were inconsistent with diagnosis of postdural
puncture headache.
Discussion
Similar to previous studies in children, our study
shows a reduction in intra- and postoperative opioid
Table 2 Description of perioperative data (presented as n [%] or
mean  SD)
Intrathecal
(n = 77)
Intravenous
(n = 51) P value
Anesthesia induction
(min from start to end)
43.6  13.3 37.8  16.0 0.027
Surgery duration
(min from incision to
dressing)
220.5  83.9 227.1  75.5 0.652
Anesthesia emergence
(min from dressing end
to extubation)
11.3  11.2 13.8  10.9 0.209
Preoperative
acetaminophen
20 (26%) 25 (48%) 0.010
Intraoperative medications
IV opioid administered 29 (38%) 51 (100%) <0.001
IT bupivacaine 62 NA –
Oral morphine
equivalents
(mean  SD mgkg1)
0.05  0.09 0.19  0.10 <0.001
Ketorolac 8 (10%) 22 (42%) <0.001
Local infiltration 17 (22%) 11 (21%) 0.901
Postanesthesia care medications
Opioids 14 (18%) 37 (71%) <0.001
Ketorolac 6 (8%) 5 (10%) 0.716
Oral morphine
equivalents
(mean  SD mgkg1)
0.01  0.03 0.04  0.04 <0.001
Acetaminophen 7 (9%) 3 (6%) 0.489
PACU length of stay
(min)
97.2  41.6 102.7  43.2 0.474
PACU, postanesthesia care unit; IT, intrathecal; IV, intravenous.
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use in patients who received IT opioids compared to
IV only opioids (2–4,13,14). A small majority of chil-
dren (53%) who received IT opioids did not require
an opioid rescue until ≥18 h after surgery, and more
than two-thirds transitioned directly to oral analgesics
without the need for IV opioids. Pain scores were low
for children in both groups and did not significantly
differ. These findings suggest that IT opioid analgesia
provides benefit in terms of reduced analgesic need in
the early postoperative period only; we found that
16 h after PACU discharge, both IT and IV opioid
administration were similarly efficacious in managing
postoperative pain
Our finding that IT administration of opioids reduced
postoperative opioid requirements during the early post-
operative period is consistent with those from other
studies (4,8). The length of time-to-rescue in our study is
consistent with other studies, ranging from 12.3 to
22.9 h depending on the dose of IT morphine (3,15).
Such data regarding the expected time to need for anal-
gesic rescue may facilitate effective transition to oral or
IV opioid or adjuvant analgesics and thereby avoid
severe unrelieved pain. As seen in Figure 1, we found a
consistent albeit modest increase in pain intensity in our
IT group at the time we expected the IT analgesia to
become ineffective. Early supplementation with
nonopioid agents during the early postoperative period
in our study may have resulted in only modest increase
in pain scores once IT analgesia wore off with elimina-
tion of opioid need altogether in some patients.
The relatively high incidence of bothersome but non-
serious adverse effects in our sample is higher than has
been previously reported. Our incidence of nausea and
vomiting was roughly double that found in studies (7,8)
where more than 100 children were followed up for
48 h. Lower rates of nausea and vomiting (between 6%
and 8%) may reflect very short follow-up times (3) or
less major surgical procedures (2). The high incidence of
pruritus in our IT group is similar to that reported in
other studies (7). Lower rates of pruritus (e.g., 10%)
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Figure 1 Reported pain scores in the groups
over time.
Table 3 Description of Adverse events (n [%])
Intrathecal
(n = 77) (%)
Intravenous
(n = 51) (%) P value
Overall analgesic-related
adverse events
58 (75) 32 (67) 0.294
Nausea  vomiting 51 (66) 30 (59) 0.395
Antiemetic 39 (51) 25 (49)
Pruritus 31 (40) 7 (14) 0.001
Diphenhydramine 15 (20) 7 (14)
Constipation requiring
laxative
23 (30) 7 (13) 0.035
Urinary retention 4 (5) 1 (2) 0.647
Bladder spasm 22 (29) 13 (26) 0.702
Oxygen desaturation
(SpO2 <92%)
7 (9) 4 (8) 0.647
Supplemental O2 5 (7) 5 (10) 0.432
Over-sedation 2 (3) 1 (2) 1.00
Naloxone given 2 (3) 0 0.517
Hypotension requiring
fluid bolus
14 (18) 2 (4) 0.026
Unplanned ICU admission 1 (1.3) 0 1.00
Postdural headache 2 (3) NA –
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have been found for children treated prophylactically
with naloxone infusion (6) and in those not followed
beyond the early postoperative period (2). Interestingly,
we found a higher rate of constipation in the IT group
vs the IV group, a comparison that has not been made
in previous studies. Our incidence of respiratory depres-
sion is similar to other studies with incidence varying
from 1% to 10% across a range of follow-up periods.
Two children in our sample required naloxone. While an
overdose was suspected, these children may have been
highly sensitive to opioids. This highlights the need for
safety measures for children receiving opioids via any
route. These should include postoperative monitoring
(e.g., pulse oximetry), careful drug preparation, delivery,
and ‘time-outs’.
Despite somewhat equivocal findings regarding bene-
fits and risks in our study, administering morphine
intrathecally may offer some advantages over other
routes of opioid administration. Firstly, the procedure
itself has a clear end point (free flow of CSF) compared
with other regional methods, such as epidural adminis-
tration. In our study, we found a high success rate for
IT analgesia (i.e., 86%) similar to other studies (7) and
the majority of failures had been identified at the time of
attempted IT injection. Secondly, IT administration
requires smaller opioid doses than intravenous or alter-
native regional routes, as it enables direct access to cen-
tral and spinal cord opiate receptors (16). Overall,
children in our IT group received lower doses of opioids
both intraoperatively and postoperatively. In theory,
lower overall opioid doses should be associated with
fewer side effects; however, this was not the case. In our
study and others, similar adverse effects were found
when opioids are given via IT and IV routes. Thus, the
opioid-sparing effect of IT opioids has, to date, not been
associated with a decrease in opioid-related adverse
effects and a much larger sample may be needed to
demonstrate this effect. Finally, there may be a cost
benefit related to the rapid transition to oral analgesia
and reduced need for IV medications or PCA pump
equipment during the hospital stay.
The retrospective nature of this study introduces
several potential biases that may limit the interpreta-
tion of our data. Firstly, data were collected over the
period where the IT technique was first introduced
which may have inflated our failure rate. Additionally,
our pain and adverse event outcomes were based
solely on medical record documentation which
introduces a significant potential of reporting bias.
However, given that documentation of these outcomes
is mandatory by institutional standards and captured
electronically, our concern for this bias is lessened.
Our study also has strengths that have not been noted
previously. These include a rigorous exclusion and
inclusion criteria which has not been used in previous
retrospective studies. Further, we limited our sample
to a large group of children operated on by the same
urologic surgeons over a small time period. Generaliz-
ing our findings beyond this setting may be difficult
given potential differences in surgical, anesthetic, and
postoperative practices. However, similar findings in
our study as in previous studies, lend external validity
to our findings.
Conclusions
In summary, the intraoperative administration of IT
opioids in our sample was associated with better post-
operative analgesic efficacy than IV opioids alone dur-
ing PACU stay and for the first 16 h after PACU
discharge. Additionally, intraoperative administration
of IT opioid was associated with a delayed need and/
or no need for intravenous opioid rescue analgesics for
a majority of children. We found higher rates of the
opioid-related adverse outcomes of pruritus, constipa-
tion, and hypotension in the IT group. These data can
be used to inform perioperative and postoperative
analgesic management for children undergoing major
urologic surgery with an aim to improve safe and
effective use of opioids.
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